PMC:7594251 / 2484-2627 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7594251","sourcedb":"PMC","sourceid":"7594251","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7594251","text":" investment barrier for drug development is a result of numerous testing phases (Scheme 1), with each phase requiring a statistically significa","tracks":[{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14710","span":{"begin":44,"end":45},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T5958","span":{"begin":65,"end":72},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T70818","span":{"begin":118,"end":119},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"attributes":[{"subj":"T14710","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T5958","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T70818","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T17","span":{"begin":24,"end":28},"obj":"Chemical"}],"attributes":[{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"subj":"T17","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CLO","color":"#95ec93","default":true},{"id":"LitCovid-PD-CHEBI","color":"#ec93af"}]}]}}